<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 4)*
MEDIMMUNE, INC.
-----------------------------------------------------------------
(Name of Issuer)
Common Stock $.01 par value
-----------------------------------------------------------------
(Title of Class of Securities)
584699102
-----------------------------------------------------------------
(CUSIP Number)
Check the following box if a fee is being paid with this
statement [ ]. (A fee is not required only if the reporting
person: (1) has a previous statement on file reporting beneficial
ownership of more than five percent of the class of securities
described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of
such class.) (See Rule 13d-7.)
*The remainder of this cover page shall be filled out for a
reporting person's initial filing on this form with respect to
the subject class of securities, and for any subsequent amendment
containing information which would alter the disclosures provided
in a prior cover page.
The information required in the remainder of this cover page
shall not be deemed to be "filed" for the purpose of Section 18
of the Securities Exchange Act of 1934 ("Act") or otherwise
subject to the liabilities of that section of the Act but shall
be subject to all other provisions of the Act (however, see the
Notes).
(Continued on following page(s))
Page 1 of 14 pages
-- --
<PAGE>
CUSIP No. 584699102 13G Page 2 of 14 pages
------------ ----- -----
-------------------------------------------------------------------
1. NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
HealthCare Ventures I, L.P.
-------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ]
(b) [ ]
-------------------------------------------------------------------
3. SEC USE ONLY
-------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
-------------------------------------------------------------------
5. SOLE VOTING POWER
-----------------------------------------------
NUMBER OF 6. SHARED VOTING POWER
SHARES
BENEFICIALLY 5,291,430
OWNED BY -----------------------------------------------
EACH 7. SOLE DISPOSITIVE POWER
REPORTING
PERSON
WITH -----------------------------------------------
8. SHARED DISPOSITIVE POWER
5,291,430
-------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
5,291,430
-------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES* [ ]
-------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
22.4%
-------------------------------------------------------------------
12. TYPE OF REPORTING PERSON*
PN
-------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
CUSIP No. 584699102 13G Page 3 of 14 pages
------------ ----- -----
-------------------------------------------------------------------
1. NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
HealthCare Partners I, L.P.
-------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ]
(b) [ ]
-------------------------------------------------------------------
3. SEC USE ONLY
-------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
-------------------------------------------------------------------
5. SOLE VOTING POWER
-----------------------------------------------
NUMBER OF 6. SHARED VOTING POWER
SHARES
BENEFICIALLY 5,291,430
OWNED BY -----------------------------------------------
EACH 7. SOLE DISPOSITIVE POWER
REPORTING
PERSON
WITH -----------------------------------------------
8. SHARED DISPOSITIVE POWER
5,291,430
-------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
5,291,430
-------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES* [ ]
-------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
22.4%
-------------------------------------------------------------------
12. TYPE OF REPORTING PERSON*
PN
-------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
CUSIP No. 584699102 13G Page 4 of 14 pages
------------ ----- -----
-------------------------------------------------------------------
1. NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
HealthCare Ventures II, L.P.
-------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ]
(b) [ ]
-------------------------------------------------------------------
3. SEC USE ONLY
-------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
-------------------------------------------------------------------
5. SOLE VOTING POWER
-----------------------------------------------
NUMBER OF 6. SHARED VOTING POWER
SHARES
BENEFICIALLY 654,677
OWNED BY -----------------------------------------------
EACH 7. SOLE DISPOSITIVE POWER
REPORTING
PERSON
WITH -----------------------------------------------
8. SHARED DISPOSITIVE POWER
654,677
-------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
654,677
-------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES* [ ]
-------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
3.0%
-------------------------------------------------------------------
12. TYPE OF REPORTING PERSON*
PN
-------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
CUSIP No. 584699102 13G Page 5 of 14 pages
------------ ----- -----
-------------------------------------------------------------------
1. NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
HealthCare Partners II, L.P.
-------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ]
(b) [ ]
-------------------------------------------------------------------
3. SEC USE ONLY
-------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
-------------------------------------------------------------------
5. SOLE VOTING POWER
-----------------------------------------------
NUMBER OF 6. SHARED VOTING POWER
SHARES
BENEFICIALLY 654,677
OWNED BY -----------------------------------------------
EACH 7. SOLE DISPOSITIVE POWER
REPORTING
PERSON
WITH -----------------------------------------------
8. SHARED DISPOSITIVE POWER
654,677
-------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
654,677
-------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES* [ ]
-------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
3.0%
-------------------------------------------------------------------
12. TYPE OF REPORTING PERSON*
PN
-------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
CUSIP No. 584699102 13G Page 6 of 14 pages
------------ ----- -----
-------------------------------------------------------------------
1. NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
James H. Cavanaugh, Ph.D.
-------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ]
(b) [ ]
-------------------------------------------------------------------
3. SEC USE ONLY
-------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
United States
-------------------------------------------------------------------
5. SOLE VOTING POWER
-----------------------------------------------
NUMBER OF 6. SHARED VOTING POWER
SHARES
BENEFICIALLY 5,946,107
OWNED BY -----------------------------------------------
EACH 7. SOLE DISPOSITIVE POWER
REPORTING
PERSON
WITH -----------------------------------------------
8. SHARED DISPOSITIVE POWER
5,946,107
-------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
5,946,107
-------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES* [ ]
-------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
25.2%
-------------------------------------------------------------------
12. TYPE OF REPORTING PERSON*
IN
-------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
CUSIP No. 584699102 13G Page 7 of 14 pages
------------ ----- -----
-------------------------------------------------------------------
1. NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Harold R. Werner
-------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ]
(b) [ ]
-------------------------------------------------------------------
3. SEC USE ONLY
-------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
United States
-------------------------------------------------------------------
5. SOLE VOTING POWER
-----------------------------------------------
NUMBER OF 6. SHARED VOTING POWER
SHARES
BENEFICIALLY 5,946,107
OWNED BY -----------------------------------------------
EACH 7. SOLE DISPOSITIVE POWER
REPORTING
PERSON
WITH -----------------------------------------------
8. SHARED DISPOSITIVE POWER
5,946,107
-------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
5,946,107
-------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES* [ ]
-------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
25.2%
-------------------------------------------------------------------
12. TYPE OF REPORTING PERSON*
IN
-------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
CUSIP No. 584699102 13G Page 8 of 14 pages
------------ ----- -----
-------------------------------------------------------------------
1. NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
John W. Littlechild
-------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ]
(b) [ ]
-------------------------------------------------------------------
3. SEC USE ONLY
-------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
United States
-------------------------------------------------------------------
5. SOLE VOTING POWER
-----------------------------------------------
NUMBER OF 6. SHARED VOTING POWER
SHARES
BENEFICIALLY 5,946,107
OWNED BY -----------------------------------------------
EACH 7. SOLE DISPOSITIVE POWER
REPORTING
PERSON
WITH -----------------------------------------------
8. SHARED DISPOSITIVE POWER
5,946,107
-------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
5,946,107
-------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES* [ ]
-------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
25.2%
-------------------------------------------------------------------
12. TYPE OF REPORTING PERSON*
IN
-------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
CUSIP No. 584699102 13G Page 9 of 14 pages
------------ ----- -----
-------------------------------------------------------------------
1. NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
William Crouse
-------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ]
(b) [ ]
-------------------------------------------------------------------
3. SEC USE ONLY
-------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
United States
-------------------------------------------------------------------
5. SOLE VOTING POWER
-----------------------------------------------
NUMBER OF 6. SHARED VOTING POWER
SHARES
BENEFICIALLY 5,946,107
OWNED BY -----------------------------------------------
EACH 7. SOLE DISPOSITIVE POWER
REPORTING
PERSON
WITH -----------------------------------------------
8. SHARED DISPOSITIVE POWER
5,946,107
-------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
5,946,107
-------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES* [ ]
-------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
25.2%
-------------------------------------------------------------------
12. TYPE OF REPORTING PERSON*
IN
-------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
Page 10 of 14 pages
----- -----
Item 1.
(a) Name of Issuer:
MedImmune, Inc.
(b) Address of Issuer's Principal Executive Offices:
35 West Watkins Mill Road
Gaithersburg, Maryland 20878
Item 2.
(a) Name of Person Filing:
HealthCare Ventures I, L.P. ("HCV I"), HealthCare Partners I,
L.P. ("HCP I"), HealthCare Ventures II, L.P. ("HCV II"),
HealthCare Partners II, L.P. ("HCP II"), Dr. Cavanaugh and
Messrs. Werner, Littlechild and Crouse. See attached Exhibit A
which is a copy of their agreement in writing to file this
statement on behalf of each of them.(1)
(b) Address of Principal Business Office or, if none, Residence:
The business address for HCV I, HCP I, HCV II, HCP II, Dr.
Cavanaugh, and Messrs. Werner and Crouse is Twin Towers at
Metro Park, 379 Thornall Street, Edison, New Jersey 08837. The
business address for Mr. Littlechild is One Kendall Square,
Building 300, Cambridge, Massachusetts 02139.
(c) Citizenship:
HCV I, HCP I, HCV II and HCP II are limited partnerships
organized under the laws of the State of Delaware. Dr.
Cavanaugh and Messrs. Werner, Littlechild and Crouse are each
United States citizens.
(d) Title of Class of Securities:
Common Stock, par value $.01 ("Shares").
- --------
(1) Dr. Cavanaugh and Messrs. Werner, Littlechild and Crouse are
general partners of HCP I and HCP II, which are the general
partners of HCV I and HCV II, respectively, the record holder
of Issuer's securities.
<PAGE>
Page 11 of 14 pages
----- -----
(e) CUSIP Number:
584699102
Item 3. If this statement is filed pursuant to Rule 13d-1(b), or
13d-2(b), check whether the person filing is a:
Inapplicable.
Item 4. Ownership.
(a) Amount Beneficially Owned:
As of December 31, 1996: HCV I and HCP I beneficially owned
5,291,430 Shares of the Issuer's securities, consisting of
3,353,590 Shares of Issuer's Common Stock and immediately
exercisable warrants to purchase 1,937,840 Shares of Issuer's
Common Stock; HCV II and HCP II beneficially owned 654,677
Shares of Issuer's Common Stock; and Dr. Cavanaugh and Messrs.
Werner, Littlechild and Crouse beneficially owned 5,946,107
Shares of Issuer's securities, consisting of 4,008,267 Shares
of Issuer's Common Stock and immediately exercisable warrants
to purchase 1,937,840 Shares of Issuer's Common Stock.
(b) Percent of Class:
As of December 31, 1996: the 5,291,430 Shares of Issuer's
securities beneficially owned by HCV I and HCP I constitute
22.4% of Issuer's Shares outstanding; the 654,677 Shares of
Issuer's securities beneficially owned by HCV II and HCP II
constitute 3.0% of Issuer's Shares outstanding; and the
5,946,107 Shares of Issuer's securities beneficially owned by
Dr. Cavanaugh and Messrs. Werner, Littlechild and Crouse
constitute 25.2% of Issuer's Shares outstanding.
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote:
Inapplicable.
(ii) shared power to vote or to direct the vote: HCV I,
HCP I, Dr. Cavanaugh and Messrs. Werner, Littlechild
and Crouse share the power to vote or direct the vote
of those shares owned by HCV I.
<PAGE>
Page 12 of 14 pages
----- -----
HCV II, HCP II, Dr. Cavanaugh and Messrs. Werner,
Littlechild and Crouse share the power to vote or to
direct the vote of those shares owned by HCV II.
(iii) sole power to dispose or to direct the disposition
of:
Inapplicable.
(iv) shared power to dispose of or to direct the
disposition of: HCV I, HCP I, Dr. Cavanaugh and
Messrs. Werner, Littlechild and Crouse share the
power to dispose of or direct the disposition of
those shares owned by HCV I.
HCV II, HCP II, Dr. Cavanaugh and Messrs. Werner,
Littlechild and Crouse share the power to dispose of
or to direct the disposition of those shares owned by
HCV II.
Item 5. Ownership of Five Percent or less of a Class:
Inapplicable.
Item 6. Ownership of More than Five Percent on Behalf of Another
Person:
Inapplicable.
Item 7. Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported on by the Parent Holding
Company:
Inapplicable.
Item 8. Identification and Classification of Members of the Group:
Inapplicable.
Item 9. Notice of Dissolution of Group:
Inapplicable.
Item 10. Certification:
Inapplicable.
<PAGE>
Page 13 of 14 pages
----- -----
SIGNATURES
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
<TABLE>
<S> <C>
Dated: February 13, 1997 HealthCare Ventures I, L.P.,
Edison, New Jersey by its General Partner, HealthCare
Partners I, L.P.
By: /s/ Jeffrey Steinberg
----------------------------
Administrative Partner
Dated: February 13, 1997 HealthCare Partners I, L.P.
Edison, New Jersey
By: /s/ Jeffrey Steinberg
----------------------------
Administrative Partner
Dated: February 13, 1997 HealthCare Ventures II, L.P.,
Edison, New Jersey by its General Partner, HealthCare
Partners II, L.P.
By: /s/ Jeffrey Steinberg
----------------------------
Administrative Partner
Dated: February 13, 1997 HealthCare Partners II, L.P.
Edison, New Jersey
By: /s/ Jeffrey Steinberg
----------------------------
Administrative Partner
Dated: February 13, 1997 By: /s/ Jeffrey Steinberg as Attorney-in-Fact
Edison, New Jersey ----------------------------
James H. Cavanaugh, Ph.D.
Dated: February 13, 1997 By: /s/ Jeffrey Steinberg as Attorney-in-Fact
Edison, New Jersey ----------------------------
Harold R. Werner
Dated: February 13, 1997 By: /s/ Jeffrey Steinberg as Attorney-in-Fact
Cambridge, Massachusetts ----------------------------
John W. Littlechild
Dated: February 13, 1997 By: /s/ Jeffrey Steinberg as Attorney-in-Fact
Edison, New Jersey ----------------------------
William Crouse
</TABLE>
<PAGE>
Page 14 of 14 pages
----- -----
EXHIBIT A
AGREEMENT
JOINT FILING OF SCHEDULE 13G
The undersigned hereby agree to jointly prepare and file with regulatory
authorities a Schedule 13G and any future amendments thereto reporting each of
the undersigned's ownership of securities of MedImmune, Inc. and hereby affirm
that such Schedule 13G is being filed on behalf of each of the undersigned.
<TABLE>
<S> <C>
Dated: February 13, 1997 HealthCare Ventures I, L.P.,
Edison, New Jersey by its General Partner, HealthCare
Partners I, L.P.
By: /s/ Jeffrey Steinberg
------------------------------
Administrative Partner
Dated: February 13, 1997 HealthCare Partners I, L.P.
Edison, New Jersey
By: /s/ Jeffrey Steinberg
------------------------------
Administrative Partner
Dated: February 13, 1997 HealthCare Ventures II, L.P.,
Edison, New Jersey by its General Partner, HealthCare
Partners II, L.P.
By: /s/ Jeffrey Steinberg
------------------------------
Administrative Partner
Dated: February 13, 1997 HealthCare Partners II, L.P.
Edison, New Jersey
By: /s/ Jeffrey Steinberg
------------------------------
Administrative Partner
Dated: February 13, 1997 By: /s/ Jeffrey Steinberg as Attorney-in-Fact
Edison, New Jersey ------------------------------
James H. Cavanaugh, Ph.D.
Dated: February 13, 1997 By: /s/ Jeffrey Steinberg as Attorney-in-Fact
Edison, New Jersey -----------------------------
Harold R. Werner
Dated: February 13, 1997 By: /s/ Jeffrey Steinberg as Attorney-in-Fact
Cambridge, Massachusetts -----------------------------
John W. Littlechild
Dated: February 13, 1997 By: /s/ Jeffrey Steinberg as Attorney-in-Fact
Edison, New Jersey -----------------------------
William Crouse
</TABLE>
